Search | IOVS | ARVO Journals

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Melatonin and agomelatine improved effects on the IOP

Dario Rusciano; Nicola Pescosolido; Salvatore Pezzino; Rosario Pignatello; Roberta Corsaro; Massimo Dal Monte; Maurizio Cammalleri; Paola Bagnoli

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3786. doi:

ARVO Annual Meeting Abstract July 2018

UPARANT is an effective antiangiogenic in a novel mouse model of rubeosis iridis associated with neovascular glaucoma

Helder Andre; Filippo Locri; Monica Aronsson; Maurizio Cammalleri; Massimo Dal Monte; Paola Bagnoli; Mario De Rosa; Vincenzo Pavone; Anders P Kvanta

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1251. doi:

ARVO Annual Meeting Abstract June 2017

EFFICACY OF A NEW FOOD SUPPLEMENT IN A MURINE MODEL OF ATROPHIC AMD

Dario Rusciano; Maddalena Balestra; Massimo Dal Monte; Maurizio Cammalleri; Filippo Locri; Paola Bagnoli

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1988. doi:

ARVO Annual Meeting Abstract June 2017

The Urokinase Receptor-Derived Peptide UPARANT as a novel therapy to recover high glucose-associated retinal damage in spontaneously diabetic Torii rats

Stefania Marsili; Maurizio Cammalleri; Filippo Locri; Massimo Dal Monte; Dario Rusciano; Vincenzo Pavone; Mario De Rosa; Paola Bagnoli

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5802. doi:

Biochemistry and Molecular Biology June 2017

The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood–Retinal Barrier Leakage in a Rat Model of Diabetes

PDF

Maurizio Cammalleri; Filippo Locri; Stefania Marsili; Massimo Dal Monte; Claudio Pisano; Angelo Mancinelli; Liliana Lista; Dario Rusciano; Mario De Rosa; Vincenzo Pavone; Paola Bagnoli
TAGS: diabetes mellitus, urokinase, blood-retinal barrier, electroretinography, peptides, eye, rats, retina
Invest. Ophthalmol. Vis. Sci.. 2017; 58(7):3138-3148. doi: 10.1167/iovs.17-21593

Includes: Supplemental Content

ARVO Annual Meeting Abstract September 2016

The uPAR/FPR antagonist UPARANT shows anti-angiogenic and antinflammatory properties in rodent models of retinal neovascular diseases.

Dario Rusciano; Paola Bagnoli; Helder André; Massimo Dal Monte; Maurizio Cammalleri; Filippo Locri; Monica Aronsson; Anders P Kvanta; Liliana Lista; Vincenzo Pavone; Mario De Rosa

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1114. doi:

Retinal Cell Biology June 2016

VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy

PDF

Rosario Amato; Martina Biagioni; Maurizio Cammalleri; Massimo Dal Monte; Giovanni Casini
TAGS: vascular endothelial growth factor a, diabetic retinopathy, prognostic factors, pituitary adenylate cyclase activating polypeptide
Invest. Ophthalmol. Vis. Sci.. 2016; 57(7):3066-3076. doi: 10.1167/iovs.16-19285

Includes: Supplemental Content

Biochemistry and Molecular Biology May 2016

The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization

PDF

Maurizio Cammalleri; Massimo Dal Monte; Filippo Locri; Liliana Lista; Monica Aronsson; Anders Kvanta; Dario Rusciano; Mario De Rosa; Vincenzo Pavone; Helder André; Paola Bagnoli

Invest. Ophthalmol. Vis. Sci.. 2016; 57(6):2600-2611. doi: 10.1167/iovs.15-18758

Includes: Supplemental Content

Biochemistry and Molecular Biology April 2015

Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy

PDF

Massimo Dal Monte; Sara Rezzola; Maurizio Cammalleri; Mirella Belleri; Filippo Locri; Lucia Morbidelli; Michela Corsini; Giuseppe Paganini; Francesco Semeraro; Anna Cancarini; Dario Rusciano; Marco Presta; Paola Bagnoli
TAGS: angiogenesis, oxygen, vascular endothelial growth factor a, inflammatory markers, endothelial cells, urokinase, angiogenesis inhibitors, electroretinography, peptides, retinal diseases
Invest. Ophthalmol. Vis. Sci.. 2015; 56(4):2392-2407. doi: 10.1167/iovs.14-16323

Includes: Supplemental Content

Biochemistry and Molecular Biology January 2015

Protective Effects of β1/2 Adrenergic Receptor Deletion in a Model of Oxygen-Induced Retinopathy

PDF

Massimo Dal Monte; Maurizio Cammalleri; Elisabetta Mattei; Luca Filippi; Paola Bagnoli
TAGS: angiogenesis, oxygen, vascular endothelial growth factor a, nitrites, adrenergic receptor, replication origin, retinal diseases, mice, retina
Invest. Ophthalmol. Vis. Sci.. 2015; 56(1):59-73. doi: 10.1167/iovs.14-15263

Includes: Supplemental Content

Biochemistry and Molecular Biology January 2011

Role of the Adrenergic System in a Mouse Model of Oxygen-Induced Retinopathy: Antiangiogenic Effects of β-Adrenoreceptor Blockade

PDF

Chiara Ristori; Luca Filippi; Massimo Dal Monte; Davide Martini; Maurizio Cammalleri; Pina Fortunato; Giancarlo la Marca; Patrizio Fiorini; Paola Bagnoli
TAGS: propranolol, oxygen, vascular endothelial growth factor a, adrenergic system, hypoxia, angiogenesis inhibitors, insulin-like growth factor i, insulin-like-growth factor i receptor, adrenergic receptor, replication origin
Invest. Ophthalmol. Vis. Sci.. 2011; 52(1):155-170. doi: 10.1167/iovs.10-5536

Biochemistry and Molecular Biology August 2009

Effects of Somatostatin Analogues on Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy: Involvement of the Somatostatin Receptor Subtype 2

PDF

Massimo Dal Monte; Chiara Ristori; Maurizio Cammalleri; Paola Bagnoli
TAGS: angiogenesis, oxygen, vascular endothelial growth factor a, vascular endothelial growth factor receptor-2, vegfr-1, hypoxia, neovascularization, pathologic, octreotide, somatostatin receptor, retinal diseases
Invest. Ophthalmol. Vis. Sci.. 2009; 50(8):3596-3606. doi: 10.1167/iovs.09-3412

Biochemistry and Molecular Biology August 2007

Antiangiogenic Role of Somatostatin Receptor 2 in a Model of Hypoxia-Induced Neovascularization in the Retina: Results from Transgenic Mice

PDF

Massimo Dal Monte; Maurizio Cammalleri; Davide Martini; Giovanni Casini; Paola Bagnoli
TAGS: vascular endothelial growth factor a, hypoxia, angiogenesis inhibitors, insulin-like growth factor i, mice, transgenic, neovascularization, pathologic, insulin-like-growth factor i receptor, somatostatin receptor, rna, messenger, retina
Invest. Ophthalmol. Vis. Sci.. 2007; 48(8):3480-3489. doi: 10.1167/iovs.06-1469

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Melatonin and agomelatine improved effects on the IOP

UPARANT is an effective antiangiogenic in a novel mouse model of rubeosis iridis associated with neovascular glaucoma

EFFICACY OF A NEW FOOD SUPPLEMENT IN A MURINE MODEL OF ATROPHIC AMD

The Urokinase Receptor-Derived Peptide UPARANT as a novel therapy to recover high glucose-associated retinal damage in spontaneously diabetic Torii rats

The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood–Retinal Barrier Leakage in a Rat Model of Diabetes

The uPAR/FPR antagonist UPARANT shows anti-angiogenic and antinflammatory properties in rodent models of retinal neovascular diseases.

VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy

The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization

Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy

Protective Effects of β1/2 Adrenergic Receptor Deletion in a Model of Oxygen-Induced Retinopathy

Role of the Adrenergic System in a Mouse Model of Oxygen-Induced Retinopathy: Antiangiogenic Effects of β-Adrenoreceptor Blockade

Effects of Somatostatin Analogues on Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy: Involvement of the Somatostatin Receptor Subtype 2

Antiangiogenic Role of Somatostatin Receptor 2 in a Model of Hypoxia-Induced Neovascularization in the Retina: Results from Transgenic Mice

To View More...

You must be signed into an individual account to use this feature.